11 Overview • Our CRO services include integrated discovery (“Discovery”) capabilities across biology, chemistry, and drug metabolism and pharmacokinetics (“DMPK”). We have provided services for more than 140 small molecule discovery programs in the past five years and to more than 100 customers in the past three years. We provide Discovery services through our Unit II Hyderabad facility and Greater Boston facility. • Our CDMO services include comprehensive capabilities that support our customers in the development and scaling up production of active pharmaceutical ingredients and intermediates for clinical phase and commercial phase supplies. We provide these CMC services through our Bidar facility, Hyderabad facility and Manchester Facility. Our CMC services are broadly classified as early-phase (pre-clinical to Phase II) and late phase (commercial, Phase III and post-Phase-III products). Excellence in Digitalizing Learning & Development, 2023 by ISTD AAALAC International full Accederation for the animal house Ecovadis Silver Awarded as “Excellent Energy Efficient Unit” at CII’s 24th National Energy Management Awards for the fourth consecutive year Winner of Gold in Brandon Hall Group’s Excellence in Technology Awards in “Best Advance in Content Authoring Technology” category Awards & Certifications We are also one of the few Indian CRDMOs to combine discovery and development operations in the US, the UK and India, with manufacturing capabilities in India. We have strategic presence, located in close proximity to innovation clusters in Boston, US and Manchester, UK.
RkJQdWJsaXNoZXIy MTIwMDc4NQ==